As highlighted by Righi et al., the diagnosis of synovial sarcoma is ideally based on a combination of morphological and immunohistochemical features, with molecular confirmation of the SS18-SSX fusion considered desirable, particularly for unusual presentations or small biopsies. The gene discussed is SS18; the disease is synovial sarcoma.